CASI PHARMACEUTICALS INC - COM (CASI)

CUSIP: 14757U109

Q4 2018 13F Holders as of 31 Dec 2018

Type / Class
Equity / COM
Total 13F shares
11,417,745
Share change
+671,154
Total reported value
$45,896,953
Price per share
$4.02
Number of holders
50
Value change
+$2,570,804
Number of buys
24
Number of sells
23

Quarterly Holders Quick Answers

What is CUSIP 14757U109?
CUSIP 14757U109 identifies CASI - CASI PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CASI PHARMACEUTICALS INC - COM (CASI) as of Q4 2018

As of 31 Dec 2018, CASI PHARMACEUTICALS INC - COM (CASI) was held by 50 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 11,417,745 shares. The largest 10 holders included BlackRock Inc., Vanguard Group Inc, Wellington Shields Capital Management, LLC, Wellington Shields & Co., LLC, STATE STREET CORP, NORTHERN TRUST CORP, GEODE CAPITAL MANAGEMENT, LLC, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, ALPS ADVISORS INC, and Bank of New York Mellon Corp. This page lists 50 institutional shareholders reporting positions in this security for the Q4 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.